-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
PetIQ, Inc. to Post Q3 2022 Earnings of ($0.12) Per Share, Jefferies Financial Group Forecasts (NASDAQ:PETQ)
PetIQ, Inc. to Post Q3 2022 Earnings of ($0.12) Per Share, Jefferies Financial Group Forecasts (NASDAQ:PETQ)
PetIQ, Inc. (NASDAQ:PETQ – Get Rating) – Analysts at Jefferies Financial Group issued their Q3 2022 earnings per share (EPS) estimates for PetIQ in a note issued to investors on Wednesday, September 21st. Jefferies Financial Group analyst C. Grady expects that the company will post earnings per share of ($0.12) for the quarter. The consensus estimate for PetIQ's current full-year earnings is $0.86 per share. Jefferies Financial Group also issued estimates for PetIQ's Q4 2022 earnings at ($0.16) EPS, FY2022 earnings at $0.62 EPS, Q1 2023 earnings at $0.49 EPS, Q2 2023 earnings at $0.40 EPS, Q3 2023 earnings at ($0.02) EPS, Q4 2023 earnings at ($0.03) EPS and FY2023 earnings at $0.86 EPS.
Get PetIQ alerts:PetIQ (NASDAQ:PETQ – Get Rating) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.18. PetIQ had a negative net margin of 1.53% and a positive return on equity of 9.27%. The firm had revenue of $252.01 million during the quarter, compared to the consensus estimate of $259.28 million.
Separately, Raymond James decreased their price target on shares of PetIQ from $29.00 to $21.00 in a research note on Wednesday, August 10th.PetIQ Stock Performance
PetIQ stock opened at $8.33 on Friday. The company has a 50 day moving average price of $13.17 and a 200-day moving average price of $17.11. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.54 and a current ratio of 2.88. PetIQ has a fifty-two week low of $8.18 and a fifty-two week high of $27.09. The company has a market capitalization of $244.99 million, a PE ratio of -17.00, a P/E/G ratio of 1.27 and a beta of 1.52.
Hedge Funds Weigh In On PetIQ
Several institutional investors and hedge funds have recently bought and sold shares of the company. Captrust Financial Advisors grew its holdings in shares of PetIQ by 1,149.6% during the second quarter. Captrust Financial Advisors now owns 1,562 shares of the company's stock valued at $26,000 after buying an additional 1,437 shares during the last quarter. Byrne Asset Management LLC purchased a new stake in shares of PetIQ during the fourth quarter valued at $28,000. Eagle Bay Advisors LLC grew its holdings in shares of PetIQ by 142.9% during the second quarter. Eagle Bay Advisors LLC now owns 1,683 shares of the company's stock valued at $28,000 after buying an additional 990 shares during the last quarter. BNP Paribas Arbitrage SA grew its holdings in shares of PetIQ by 158.7% during the second quarter. BNP Paribas Arbitrage SA now owns 6,227 shares of the company's stock valued at $105,000 after buying an additional 3,820 shares during the last quarter. Finally, Amalgamated Bank purchased a new stake in shares of PetIQ during the first quarter valued at $107,000.
About PetIQ
(Get Rating)
PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications.
Featured Articles
- Get a free copy of the StockNews.com research report on PetIQ (PETQ)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.
PetIQ, Inc. (NASDAQ:PETQ – Get Rating) – Analysts at Jefferies Financial Group issued their Q3 2022 earnings per share (EPS) estimates for PetIQ in a note issued to investors on Wednesday, September 21st. Jefferies Financial Group analyst C. Grady expects that the company will post earnings per share of ($0.12) for the quarter. The consensus estimate for PetIQ's current full-year earnings is $0.86 per share. Jefferies Financial Group also issued estimates for PetIQ's Q4 2022 earnings at ($0.16) EPS, FY2022 earnings at $0.62 EPS, Q1 2023 earnings at $0.49 EPS, Q2 2023 earnings at $0.40 EPS, Q3 2023 earnings at ($0.02) EPS, Q4 2023 earnings at ($0.03) EPS and FY2023 earnings at $0.86 EPS.
PetIQ,Inc.(纳斯达克代码:PETQ-GET Rating)-杰富瑞金融集团的分析师在9月21日星期三发给投资者的一份报告中发布了他们对PetIQ 2022年第三季度每股收益(EPS)的估计。杰富瑞金融集团分析师C.Grady预计,该公司本季度每股收益将达到0.12美元。对PetIQ目前全年收益的普遍估计是每股0.86美元。杰富瑞金融集团还发布了对PetIQ 2022财年第四季度每股收益(0.16美元)、2022财年每股收益0.62美元、2023年第一季度每股收益0.49美元、2023年第二季度每股收益0.40美元、2023年第三季度每股收益(0.02美元)、2023年第四季度每股收益(0.03美元)和2023财年每股收益0.86美元的预期。
PetIQ (NASDAQ:PETQ – Get Rating) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.18. PetIQ had a negative net margin of 1.53% and a positive return on equity of 9.27%. The firm had revenue of $252.01 million during the quarter, compared to the consensus estimate of $259.28 million.
PetIQ(纳斯达克代码:PETQ-GET Rating)上一次公布季度收益是在8月9日(星期二)。该公司公布本季度每股收益为0.42美元,比普遍预期的0.24美元高出0.18美元。PetIQ的净利润率为负1.53%,股本回报率为正9.27%。该公司本季度营收为2.5201亿美元,而市场普遍预期为2.5928亿美元。
PetIQ Stock Performance
PetIQ股票表现
PetIQ stock opened at $8.33 on Friday. The company has a 50 day moving average price of $13.17 and a 200-day moving average price of $17.11. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.54 and a current ratio of 2.88. PetIQ has a fifty-two week low of $8.18 and a fifty-two week high of $27.09. The company has a market capitalization of $244.99 million, a PE ratio of -17.00, a P/E/G ratio of 1.27 and a beta of 1.52.
PetIQ的股票上周五开盘报8.33美元。该公司的50日移动均线价格为13.17美元,200日移动均线价格为17.11美元。该公司的负债权益比率为1.69,速动比率为1.54,流动比率为2.88。PetIQ的52周低点为8.18美元,52周高点为27.09美元。该公司市值为2.4499亿美元,市盈率为-17.00,市盈率为1.27,贝塔系数为1.52。
Hedge Funds Weigh In On PetIQ
对冲基金对PetIQ的看法
Several institutional investors and hedge funds have recently bought and sold shares of the company. Captrust Financial Advisors grew its holdings in shares of PetIQ by 1,149.6% during the second quarter. Captrust Financial Advisors now owns 1,562 shares of the company's stock valued at $26,000 after buying an additional 1,437 shares during the last quarter. Byrne Asset Management LLC purchased a new stake in shares of PetIQ during the fourth quarter valued at $28,000. Eagle Bay Advisors LLC grew its holdings in shares of PetIQ by 142.9% during the second quarter. Eagle Bay Advisors LLC now owns 1,683 shares of the company's stock valued at $28,000 after buying an additional 990 shares during the last quarter. BNP Paribas Arbitrage SA grew its holdings in shares of PetIQ by 158.7% during the second quarter. BNP Paribas Arbitrage SA now owns 6,227 shares of the company's stock valued at $105,000 after buying an additional 3,820 shares during the last quarter. Finally, Amalgamated Bank purchased a new stake in shares of PetIQ during the first quarter valued at $107,000.
几家机构投资者和对冲基金最近买卖了该公司的股票。CapTrust Financial Advisors在第二季度增持了1,149.6%的PetIQ股票。CapTrust Financial Advisors现在拥有1,562股该公司股票,价值26,000美元,在上个季度又购买了1,437股。Byrne Asset Management LLC在第四季度购买了PetIQ的新股,价值2.8万美元。Eagle Bay Advisors LLC在第二季度持有的PetIQ股票增加了142.9%。Eagle Bay Advisors LLC现在拥有1,683股该公司的股票,价值28,000美元,在上个季度又购买了990股。法国巴黎银行套利公司在第二季度持有的PetIQ股票增加了158.7%。法国巴黎银行套利公司现在持有该公司6,227股股票,价值10.5万美元,在上个季度又购买了3,820股。最后,合并银行在第一季度购买了PetIQ的新股份,价值10.7万美元。
About PetIQ
关于PetIQ
(Get Rating)
(获取评级)
PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications.
PetIQ,Inc.在美国和国际上作为一家宠物药物和健康公司运营。它分为两个部分,产品和服务。该公司提供Rx宠物药物,其中包括跳蚤和扁虱控制、心线虫预防、关节炎、甲状腺、糖尿病和疼痛治疗、抗生素和其他特殊药物;并开发和制造自己的专有价值品牌产品,以及分销第三方品牌药物。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on PetIQ (PETQ)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 免费获取StockNews.com关于PetIQ(PETQ)的研究报告
- MarketBeat:回顾一周9/19-9/23
- 为什么特斯拉的股票保持弹性?
- 需要关注的2只半导体类股走势逆转
- CrowdStrike是否会从增加每股收益指引中获得提振?
- 好市多盈利后价格疲软是买入的好时机吗?
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.
接受PetIQ Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对PetIQ和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧